Based on the aforementioned data, we hypothesized that miR-212-3p regulates the NLRP3/Caspase-1 signaling pathway through suppression of the SP1/BACE1 axis to attenuate neuroinflammation in AD. Here, SP1 is linked to Alzheimer disease.